A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

NCT02571036 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumors
Advanced Systemic Mastocytosis
Advanced Cancers

Interventions

DRUG: DCC-2618
DRUG: DCC-2618

Sponsor

Deciphera Pharmaceuticals, LLC